<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="Dorp et al. estimated that the initial timing of human" exact="infection" post="with SARS-CoV-2 may have been in early December or"/>
 <result pre="and improved the progression of COVID-19 pneumonia after CQ phosphate" exact="treatment" post="with no severe adverse reactions.17 Given these findings, CQ"/>
 <result pre="COVID-19. It has been thought that deaths induced by SARS-CoV-2" exact="infection" post="are due to vigorous systemic inflammation caused by â€œcytokine"/>
 <result pre="Treatment of COVID-19, different TCMs have been recommended for the" exact="treatment" post="of COVID-19.14 In the seventh edition of the Guidelines"/>
 <result pre="of the disease and stages, including medical observation period, clinical" exact="treatment" post="period, and recovery period, as shown in Table 2"/>
 <result pre="TCMs, including 21 (5.3%) examining the effects of the combined" exact="treatment" post="of TCM and Western medicine.24 A total of 92%"/>
 <result pre="(HSBDT) (shown in Table 2), were widely used in the" exact="treatment" post="of COVID-19 patients due to their significant clinical efficacy."/>
 <result pre="80 COVID-19 patients, the average duration of viral nucleic acid" exact="detection" post="was 7 (Â±4) days in the JHQGG administration group"/>
 <result pre="A total of 284 patients were randomized to receive standard" exact="treatment" post="alone or in combination with LHQWC (142 patients in"/>
 <result pre="and coughing) recovery rate was significantly higher in the combined" exact="treatment" post="group than in the control group (91.5% vs 82.4%),"/>
 <result pre="established on a different theoretical system than Western medicine, emphasizing" exact="diagnosis" post="and treatment based on the patientâ€™s overall condition rather"/>
 <result pre="a different theoretical system than Western medicine, emphasizing diagnosis and" exact="treatment" post="based on the patientâ€™s overall condition rather than targeting"/>
 <result pre="specific etiologies or pathologies. Therefore, the prescription principle of TCM" exact="treatment" post="on COVID-19 includes strengthening body resistance and eliminating pathogenic"/>
 <result pre="officially recommended TCM in combination with Western medicine in the" exact="treatment" post="of COVID-19. Table 1 Clinical Classification of COVID-19 Patients"/>
 <result pre="BID); ribavirin (500 mg by venoclysis per time, BID, combination" exact="treatment" post="with IFN-Î± or lopinavir/ritonavir are recommended); CQ phosphate (500"/>
 <result pre="dosages are suitable only for adults, and the course of" exact="treatment" post="with above antivirals should be â‰¤10 days. Monitor side"/>
 <result pre="(3) Complicated with other organ failure that requires monitoring and" exact="treatment" post="in an intensive care unit (ICU). (6) Blood dialysis."/>
 <result pre="individual conditions and clinical symptoms. Generally, one course of TCM" exact="treatment" post="lasts for 3 days; however, the period of TCM"/>
 <result pre="treatment lasts for 3 days; however, the period of TCM" exact="treatment" post="for an individual patient highly depends on the patientâ€™s"/>
 <result pre="Inhibitors of SARS-CoV-2 As a supplement to conventional medicine, TCM" exact="treatment" post="has played important roles in the campaign of managing"/>
 <result pre="Hoffmann et al.78 Mouse model Protected mice against SARS-CoV lethal" exact="infection" post="with a survival rate of 60%. SARS-CoV Zhou et"/>
 <result pre="all seven tested drugs, CQ/HCQ and RDV potently blocked viral" exact="infection" post="at low micromolar concentrations in cell cultures and showed"/>
 <result pre="excluded from their data analysis. The beneficial outcomes of HCQ" exact="treatment" post="on COVID-19 patients were also confirmed by Chen et"/>
 <result pre="to test the efficacy of HCQ and showed that HCQ" exact="treatment" post="significantly shortened the disease course.42 However, the effectiveness of"/>
 <result pre="HCQ or CQ with or without a macrolide for the" exact="treatment" post="of COVID-19, in which 96â€¯032 patients from 671 hospitals"/>
 <result pre="Therefore, the FDA withdrew the emergency approval for HCQ as" exact="treatment" post="of COVID-19 based on its ineffectiveness and serious side"/>
 <result pre="lung viral loads and improved clinical outcomes in a murine" exact="infection" post="model.53 Holshue and colleagues reported the first patient diagnosed"/>
 <result pre="in those who received placebo. This study demonstrated that RDV" exact="treatment" post="could shorten the recovery time in hospitalized COVID-19 adult"/>
 <result pre="RDV group and 79 in the placebo group) for a" exact="treatment" post="course of 10 days. RDV did not significantly shorten"/>
 <result pre="FPV FPV (T-705, 3), a guanine analog approved for influenza" exact="treatment" post="in Japan in 2014, can effectively inhibit the RNA-dependent"/>
 <result pre="COVID-19 patients was initiated to evaluate the efficacy of lopinavir/ritonavir" exact="treatment" post="in hospitals in Wuhan, China. Disappointingly, no differences were"/>
 <result pre="in Wuhan, China. Disappointingly, no differences were observed between lopinavir/ritonavir" exact="treatment" post="and standard care in clinical improvement or mortality within"/>
 <result pre="they found that lycorine protected BALB/c mice against lethal HCoV-OC43" exact="infection" post="by suppressing viral replication in the central nervous system."/>
 <result pre="that lycorine could be a broad-spectrum antiviral agent against CoV" exact="infection" post="and might offer promising therapeutic possibilities for combating SARS-CoV-2"/>
 <result pre="that camostat was effective in protecting mice from a lethal" exact="infection" post="by SARS-CoV, with a survival rate of 60%.77 Recently,"/>
 <result pre="Further in vivo studies of the two drugs against SARS-CoV-2" exact="infection" post="are recommended.16 3.2.5 Inhibitors with Undefined Replication Inhibiting Mechanisms"/>
 <result pre="alkaloids. Tetrandrine appeared to inhibit viral replication during the early" exact="infection" post="stage, likely related to interaction with the viral S"/>
 <result pre="TCM has been used for thousands of years in the" exact="treatment" post="of pandemic and endemic diseases. Since the outbreak of"/>
 <result pre="efficacy; most studies evaluating the efficacy of TCMs in the" exact="treatment" post="of SARS-CoV infections were found to be poorly designed."/>
 <result pre="clinical studies to evaluate the efficacy of TCMs in the" exact="treatment" post="of COVID-19 will be conducted using stricter protocols and"/>
 <result pre="mechanism of TCMs and avoiding potentially harmful TCMs in the" exact="treatment" post="of COVID-19. Some TCM herbs are reported to contain"/>
 <result pre="FDA has withdrawn the emergency approval for HCQ as a" exact="treatment" post="of COVID-19 based on its ineffectiveness and serious side"/>
 <result pre="in vivo antiviral activity. Suitable animal models are critical for" exact="testing" post="anti-CoV drugs. Some non-human primates were found permissive to"/>
 <result pre="pulmonary pathology, and high viral load in the lungs post-SARS-CoV-2" exact="infection" post="but no mortality.127 Therefore, the limited availability of animal"/>
 <result pre="COVID-19 patients from a large number of NSAIDs. In addition," exact="treatment" post="(especially antiviral therapy) should be started as early as"/>
 <result pre="prescriptions and therapeutic regimens and Latin names of herbs for" exact="treatment" post="(PDF) Supplementary Material LINK jm0c00626_si_001.pdf Author Contributions # N.C."/>
 <result pre="NiuJ.; WangC.; HuangB.; WangW.; ZhuN.; DengY.; WangH.; YeF.; CenS.; TanW.High-throughput" exact="screening" post="and identification of potent broad-spectrum inhibitors of coronaviruses. J."/>
 <result pre="XuS.; LiuW. R.Learning from the past: possible urgent prevention and" exact="treatment" post="options for severe acute respiratory infections caused by 2019-nCoV."/>
 <result pre="730â€&quot;738. 10.1002/cbic.202000047.32022370 JiaW.; GaoW.Is Traditional Chinese medicine useful in the" exact="treatment" post="of SARS?. Phytother. Res.2003, 17, 840â€&quot;841. 10.1002/ptr.1397.12916093 collab: National"/>
 <result pre="Y.Treatment with Lopinavir/Ritonavir or interferon- Î²1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common marmoset. J."/>
 <result pre="GaoJ.; TianZ.; YangX.Breakthrough: Chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studies. BioSci. Trends2020,"/>
 <result pre="ZhaoD.; XuY.; ShiX.; LiP.; TianX.; LinF.; CaoY.; JinL.; ChangM.; WangY.TCM" exact="treatment" post="of infectious atypical pneumonia--a report of 16 cases. J."/>
 <result pre="10476810.1016/j.phrs.2020.104768.32222346 YangY.; IslamS.; WangJ.; LiY.; ChenX.Traditional Chinese medicine in the" exact="treatment" post="of patients infected with 2019-new coronavirus (SARS-CoV-2): a review"/>
 <result pre="is highly effective in treating avian influenza A H5N1 virus" exact="infection" post="in an animal model. Cell Res.2013, 23, 300â€&quot;302. 10.1038/cr.2012.165.23208422"/>
 <result pre="Van RanstM.; MaesP.Antiviral activity of chloroquine against human coronavirus OC43" exact="infection" post="in newborn mice. Antimicrob. Agents Chemother.2009, 53, 3416â€&quot;3421. 10.1128/AAC.01509-08.19506054"/>
 <result pre="study of the safety and efficacy of chloroquine for the" exact="treatment" post="of COVID-19. medRxiv2020, 10.1101/2020.04.26.20081059. McChesneyE. W.Animal toxicity and pharmacokinetics"/>
 <result pre="ChabriÃ¨reE.; La ScolaB.; RolainJ.-M.; BrouquiP.; RaoultD.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trial."/>
 <result pre="N.RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for" exact="treatment" post="of COVID-19: a multinational registry analysis. Lancet2020, 10.1016/S0140-6736(20)31180-6. SheahanT."/>
 <result pre="H.; BonnettT.; GreenM.; MakowskiM.; OsinusiA.; NayakS.; LaneH. C.Remdesivir for the" exact="treatment" post="of Covid-19- preliminary report. N. Engl. J. Med.2020, 10.1056/NEJMoa2007764."/>
 <result pre="Lancet2020, 395, 1569â€&quot;1578. 10.1016/S0140-6736(20)31022-9.32423584 De ClercqE.New nucleoside Analogues for the" exact="treatment" post="of hemorrhagic fever virus infections. Chem. - Asian J.2019,"/>
 <result pre="Res.2013, 100, 446â€&quot;454. 10.1016/j.antiviral.2013.09.015.24084488 OestereichL.; LÃ¼dtkeA.; WurrS.; RiegerT.; MuÃ±oz-FontelaC.; GÃ¼ntherS.Successful" exact="treatment" post="of advanced ebola virus infection with T-705 (Favipiravir) in"/>
 <result pre="LÃ¼dtkeA.; WurrS.; RiegerT.; MuÃ±oz-FontelaC.; GÃ¼ntherS.Successful treatment of advanced ebola virus" exact="infection" post="with T-705 (Favipiravir) in a small animal model. Antiviral"/>
 <result pre="WangF.; LiuJ.; ChenL.; ChenS.; WangZ.; ZhangZ.; CaoR.; ZhongW.; LiuY.; LiuL.Experimental" exact="treatment" post="with favipiravir for COVID-19: an open-label control study. Engineering"/>
 <result pre="GuanY.; PeirisJ. S. M.; YuenK. Y.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findings. Thorax2004, 59,"/>
 <result pre="U. S. A.2004, 101, 10012â€&quot;10017. 10.1073/pnas.0403596101.15226499 ChandwaniA.; ShuterJ.Lopinavir/ritonavir in the" exact="treatment" post="of HIV-1 infection: a review. Ther. Clin. Risk Manage.2008,"/>
 <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin."/>
 <result pre="KwonS.Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus Oc43" exact="infection" post="of Mrc-5 human lung cells. Biomolecules2019, 9, 69610.3390/biom9110696. NgA."/>
</results>
